Pellmé Sara, Dahlgren Claes, Karlsson Anna
The Phagocyte Research Laboratory, Department of Rheumatology and Inflammation Research, University of Göteborg, Sweden.
J Immunol Methods. 2007 Aug 31;325(1-2):88-95. doi: 10.1016/j.jim.2007.06.001. Epub 2007 Jun 27.
Neutrophil function relies largely on the ability of the cell to mobilize its different granules and vesicles to the cell surface and thereby expose and/or release effector molecules to the surrounding tissue. To properly identify these subcellular compartments is thus a prerequisite for studies of neutrophil physiology. A range of specific markers for the classical granules is available, but finding optimal markers for the secretory vesicles and plasma membrane has historically been more challenging. Latent and non-latent alkaline phosphatase activities are often used to distinguish these two light membrane structures, but the outcome using this technique depends on the level of cellular activation. Therefore, HLA-I was introduced some years ago as a specific, stimulation-independent marker for the plasma membrane. In this study we however report that detailed fractionation studies of neutrophil cytoplasts, lacking secretory vesicles, granules and other dense organelles, reveal that the HLA-I antigen is not only co-localizing with the plasma membrane marker ALP, but is also present in other, more dense organelles. Further, we found the mixed enzyme-linked immunosorbent assay (MELISA), detecting the beta(2)-microglobulin/HLA-I complex, to be negatively influenced by uncomplexed beta(2)-microglobulin present in the specific granules and secretory vesicles, making it difficult to use HLA-I as a plasma membrane marker during maturation of for example phagolysosomes.
中性粒细胞的功能很大程度上依赖于细胞将其不同的颗粒和囊泡转运至细胞表面的能力,从而向周围组织暴露和/或释放效应分子。因此,正确识别这些亚细胞区室是研究中性粒细胞生理学的先决条件。目前有一系列针对经典颗粒的特异性标志物,但历史上寻找分泌囊泡和质膜的最佳标志物更具挑战性。潜在和非潜在碱性磷酸酶活性常被用于区分这两种轻膜结构,但使用该技术的结果取决于细胞活化水平。因此,几年前引入了HLA-I作为质膜的一种特异性、不依赖刺激的标志物。然而,在本研究中我们报告,对缺乏分泌囊泡、颗粒和其他致密细胞器的中性粒细胞胞质体进行详细的分级分离研究发现,HLA-I抗原不仅与质膜标志物碱性磷酸酶共定位,还存在于其他更致密的细胞器中。此外,我们发现检测β2-微球蛋白/HLA-I复合物的混合酶联免疫吸附测定(MELISA)受到特异性颗粒和分泌囊泡中存在的未复合β2-微球蛋白的负面影响,这使得在例如吞噬溶酶体成熟过程中难以将HLA-I用作质膜标志物。